What is the minimum inhibitory concentration (MIC) for imipenem (a carbapenem antibiotic) in a patient with a Serratia fonticola infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MIC for Imipenem Against Serratia fonticola

Serratia fonticola is naturally susceptible to imipenem with MIC values typically ≤1-2 mg/L, making carbapenems highly effective first-line agents for treating infections caused by this organism. 1

Natural Susceptibility Profile

  • S. fonticola demonstrates uniform natural sensitivity to carbapenems, including imipenem, based on comprehensive susceptibility testing of clinical isolates 1

  • The MIC90 (concentration inhibiting 90% of isolates) for imipenem against Serratia species is approximately 1.0 μg/mL, indicating excellent activity 2

  • All tested Serratia species isolates, including S. fonticola, have shown 100% susceptibility to imipenem in multiple studies 2, 3

Clinical Interpretation

  • MIC values ≤4 mg/L for imipenem are considered susceptible according to standard breakpoints for Enterobacteriaceae 4

  • S. fonticola MIC values for imipenem fall well below this threshold, typically in the 0.5-2.0 μg/mL range, ensuring reliable clinical efficacy 1, 5

  • Broth microdilution is the preferred method for determining accurate MIC values, though E-test and automated systems can be used with appropriate quality controls 4

Resistance Mechanisms and Considerations

  • S. fonticola naturally expresses both AmpC β-lactamases and a species-specific class A β-lactamase, but these enzymes do not confer resistance to carbapenems 1

  • Unlike some other β-lactams, imipenem maintains activity despite the presence of these naturally occurring β-lactamases in S. fonticola 1

  • The species shows natural resistance to penicillin G, oxacillin, cefazolin, and cefuroxime, but carbapenems remain fully active 1

Dosing Implications

  • For severe infections with organisms at the higher end of the susceptibility range (MIC 2-4 mg/L), prolonged or continuous infusion of carbapenems may optimize pharmacodynamic target attainment 4

  • Standard imipenem dosing achieves the pharmacodynamic target of 40% fT ≥ MIC for bacteria with MIC <4 mg/L when administered as continuous infusion at 2 g/24h 4

  • Intermittent dosing (1g every 8 hours) achieves adequate targets for MIC <2 mg/L, which encompasses typical S. fonticola susceptibility 4

Important Caveats

  • While S. fonticola is naturally susceptible to imipenem, susceptibility testing should still be performed for serious infections to detect any acquired resistance mechanisms 4

  • MIC determination is superior to simple susceptible/resistant reporting as it allows for optimization of dosing regimens, particularly in critically ill patients 4

  • The medium used for susceptibility testing can affect results; broth microdilution in Mueller-Hinton or IsoSensitest broth provides the most reliable results 1

References

Research

Serratia marcescens bacteremia: clinical features and antimicrobial susceptibilities of the isolates.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Review of imipenem.

Infection control : IC, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.